Mannan-binding-lectin-associated serine proteases, characteristics and disease associations

被引:0
作者
Rikke Sørensen
Steffen Thiel
Jens C. Jensenius
机构
[1] University of Aarhus,Department of Medical Microbiology and Immunology, Wilhelm Meyers Allé
来源
Springer Seminars in Immunopathology | 2005年 / 27卷
关键词
Carbohydrate Recognition Domain; Serine Protease Domain; Epidermal Growth Factor Domain; Active Site Serine Residue; CUB2 Fragment;
D O I
暂无
中图分类号
学科分类号
摘要
Mannan-binding lectin (MBL)-associated serine proteases (MASPs) circulate in plasma as zymogens in complexes with MBL and with L- and H-ficolin. Upon binding of MBL or ficolin to pathogen-associated molecular patterns, the MASPs are activated. MASP-2 can now cleave C4 and C2 to generate the C3 convertase, C4bC2b. The functions of the other two MASPs, MASP-1 and MASP-3 have not been elucidated. MASP-1 can cleave C2, and with low efficiency also C3, and may serve a function through direct C3 activation. No natural substrate for MASP-3 has been identified. MBL deficiency, occurring at a frequency of about 10%, is the most common congenital immunodeficiency and is associated with susceptibility to infections and autoimmune disorders. Inherited MASP-2 deficiency has been described as the result of a mutation causing the exchange of aspartic acid with a glycine at position 105, a position in the first domain, CUB1, involved in calcium binding. This mutation abolishes the binding to MBL and ficolins, and deprives MASP-2 of functional activity. The index case suffered from recurrent severe infections and autoimmune reactions. The gene frequency of the mutation among Caucasians is 3.6%. It is not found in Chinese, who present a different mutation also associated with MASP-2 deficiency.
引用
收藏
页码:299 / 319
页数:20
相关论文
共 324 条
  • [21] Kawasaki N(1994)A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein Immunogenetics 40 37-undefined
  • [22] Kawasaki T(1995)Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein J Immunol 155 3013-undefined
  • [23] Yamashina I(1998)Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America J Immunol 161 3169-undefined
  • [24] Sastry K(1992)High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene Hum Mol Genet 1 709-undefined
  • [25] Herman GA(1991)Molecular basis of opsonic defect in immunodeficient children Lancet 337 1569-undefined
  • [26] Day L(2000)Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers J Immunol Methods 241 33-undefined
  • [27] Guo N(2003)Mannose-binding lectin deficiency-revisited Mol Immunol 40 73-undefined
  • [28] Mogues T(1992)The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response Clin Exp Immunol 90 31-undefined
  • [29] Weremowicz S(1989)Association of low levels of mannan-binding protein with a common defect of opsonisation Lancet 2 1236-undefined
  • [30] Holmskov UL(2004)Mannose-binding lectin: laying the stepping stones from clinical research to personalized medicine Personalized Med 1 35-undefined